Related Experiment Videos

[Experimental application of synchronized coronary sinus retroperfusion (SCSR) and left heart bypass (LHB) for severe

M Hata1

  • 1Second Department of Surgery, Nihon University School of Medicine, Tokyo, Japan.

[Zasshi] [Journal]. Nihon Kyobu Geka Gakkai
|September 1, 1995
PubMed

Insights

Concomitant use of left heart bypass (LHB) and synchronized coronary sinus retroperfusion (SCSR) effectively treats ischemic cardiogenic shock. This combined approach significantly reduces myocardial infarction size and fully restores cardiac function, outperforming individual therapies.

Area of Science:

  • Cardiovascular Surgery
  • Cardiology
  • Biomedical Engineering

Context:

  • Ischemic cardiogenic shock often requires mechanical circulatory support beyond conventional methods like intra-aortic balloon pumping (IABP).
  • Evaluating novel combined therapies is crucial for refractory cases.

Purpose:

  • To assess the efficacy of combining left heart bypass (LHB) with synchronized coronary sinus retroperfusion (SCSR) for treating ischemic cardiogenic shock.
  • To compare the combined therapy against LHB or SCSR alone in an acute myocardial infarction model.

Summary:

  • Experimental studies in swine with acute myocardial infarction demonstrated that LHB alone improved aortic pressure and ventricular function but only slightly reduced infarct size.
  • SCSR alone remarkably reduced infarct size and gradually improved cardiac function from cardiogenic shock.
  • The combination of SCSR and LHB significantly reduced ischemic areas, fully restored cardiac function, and balanced myocardial oxygen supply-demand, addressing shock unresponsive to antegrade perfusion.

Impact:

  • This combined LHB and SCSR strategy offers a promising solution for managing severe ischemic cardiogenic shock.
  • The findings suggest a new therapeutic avenue for patients with acute myocardial infarction and refractory cardiogenic shock.

Related Concept Videos